BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

470 related articles for article (PubMed ID: 31719226)

  • 21. Microbiome and Gut Dysbiosis.
    Belizário JE; Faintuch J
    Exp Suppl; 2018; 109():459-476. PubMed ID: 30535609
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dysbiosis in Crohn's disease - Joint action of stochastic injuries and focal inflammation in the gut.
    Buttó LF; Haller D
    Gut Microbes; 2017 Jan; 8(1):53-58. PubMed ID: 28102757
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Utilizing the Gastrointestinal Microbiota to Modulate Cattle Health through the Microbiome-Gut-Organ Axes.
    Welch CB; Ryman VE; Pringle TD; Lourenco JM
    Microorganisms; 2022 Jul; 10(7):. PubMed ID: 35889109
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of the Pediatric Gut Microbiome: Impact on Health and Disease.
    Ihekweazu FD; Versalovic J
    Am J Med Sci; 2018 Nov; 356(5):413-423. PubMed ID: 30384950
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gastrointestinal tract microbiota and probiotics in production animals.
    Yeoman CJ; White BA
    Annu Rev Anim Biosci; 2014 Feb; 2():469-86. PubMed ID: 25384152
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dysbiosis and the immune system.
    Levy M; Kolodziejczyk AA; Thaiss CA; Elinav E
    Nat Rev Immunol; 2017 Apr; 17(4):219-232. PubMed ID: 28260787
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The overarching influence of the gut microbiome on end-organ function: the role of live probiotic cultures.
    Vitetta L; Manuel R; Zhou JY; Linnane AW; Hall S; Coulson S
    Pharmaceuticals (Basel); 2014 Sep; 7(9):954-89. PubMed ID: 25244509
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characteristic dysbiosis of gut microbiota of Chinese patients with diarrhea-predominant irritable bowel syndrome by an insight into the pan-microbiome.
    Wang Z; Xu CM; Liu YX; Wang XQ; Zhang L; Li M; Zhu SW; Xie ZJ; Wang PH; Duan LP; Zhu HQ
    Chin Med J (Engl); 2019 Apr; 132(8):889-904. PubMed ID: 30958430
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of Physical Exercise on Gut Microbiome, Inflammation, and the Pathobiology of Metabolic Disorders.
    Sohail MU; Yassine HM; Sohail A; Thani AAA
    Rev Diabet Stud; 2019; 15():35-48. PubMed ID: 31380886
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gut microbiome in multiple sclerosis: The players involved and the roles they play.
    Shahi SK; Freedman SN; Mangalam AK
    Gut Microbes; 2017 Nov; 8(6):607-615. PubMed ID: 28696139
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dysbiosis in intestinal inflammation: Cause or consequence.
    Buttó LF; Haller D
    Int J Med Microbiol; 2016 Aug; 306(5):302-309. PubMed ID: 27012594
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gut microbiota differs between children with Inflammatory Bowel Disease and healthy siblings in taxonomic and functional composition: a metagenomic analysis.
    Knoll RL; Forslund K; Kultima JR; Meyer CU; Kullmer U; Sunagawa S; Bork P; Gehring S
    Am J Physiol Gastrointest Liver Physiol; 2017 Apr; 312(4):G327-G339. PubMed ID: 28039159
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Microbial dysbiosis and childhood asthma development: Integrated role of the airway and gut microbiome, environmental exposures, and host metabolic and immune response.
    Liu C; Makrinioti H; Saglani S; Bowman M; Lin LL; Camargo CA; Hasegawa K; Zhu Z
    Front Immunol; 2022; 13():1028209. PubMed ID: 36248891
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Gut Microbiome in Inflammatory Bowel Disease: Lessons Learned From Other Immune-Mediated Inflammatory Diseases.
    Knox NC; Forbes JD; Peterson CL; Van Domselaar G; Bernstein CN
    Am J Gastroenterol; 2019 Jul; 114(7):1051-1070. PubMed ID: 31232832
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Understanding the Role of the Gut Microbiome and Microbial Metabolites in Obesity and Obesity-Associated Metabolic Disorders: Current Evidence and Perspectives.
    Vallianou N; Stratigou T; Christodoulatos GS; Dalamaga M
    Curr Obes Rep; 2019 Sep; 8(3):317-332. PubMed ID: 31175629
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dynamics of metatranscription in the inflammatory bowel disease gut microbiome.
    Schirmer M; Franzosa EA; Lloyd-Price J; McIver LJ; Schwager R; Poon TW; Ananthakrishnan AN; Andrews E; Barron G; Lake K; Prasad M; Sauk J; Stevens B; Wilson RG; Braun J; Denson LA; Kugathasan S; McGovern DPB; Vlamakis H; Xavier RJ; Huttenhower C
    Nat Microbiol; 2018 Mar; 3(3):337-346. PubMed ID: 29311644
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modeling environmental risk factors of autism in mice induces IBD-related gut microbial dysbiosis and hyperserotonemia.
    Lim JS; Lim MY; Choi Y; Ko G
    Mol Brain; 2017 Apr; 10(1):14. PubMed ID: 28427452
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dynamics of the human gut microbiome in inflammatory bowel disease.
    Halfvarson J; Brislawn CJ; Lamendella R; Vázquez-Baeza Y; Walters WA; Bramer LM; D'Amato M; Bonfiglio F; McDonald D; Gonzalez A; McClure EE; Dunklebarger MF; Knight R; Jansson JK
    Nat Microbiol; 2017 Feb; 2():17004. PubMed ID: 28191884
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Disruptions in gut microbial-host co-metabolism and the development of metabolic disorders.
    Rajani C; Jia W
    Clin Sci (Lond); 2018 Apr; 132(7):791-811. PubMed ID: 29661926
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intestinal microbiota in health and disease: role of bifidobacteria in gut homeostasis.
    Tojo R; Suárez A; Clemente MG; de los Reyes-Gavilán CG; Margolles A; Gueimonde M; Ruas-Madiedo P
    World J Gastroenterol; 2014 Nov; 20(41):15163-76. PubMed ID: 25386066
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.